Henry Ford Health sues CVS, alleges 340B pricing scheme

Henry Ford Health has taken legal action against CVS Health, accusing the pharmacy chain of diverting over $29 million in savings from the 340B drug pricing program, which is designed to provide discounted drugs to certain safety-net hospitals. The lawsuit claims CVS blocked agreements that would have let Henry Ford Health dispense these cheaper 340B drugs through local pharmacies, thereby unlawfully pocketing the savings. This move underscores broader tensions in healthcare about fair reimbursement practices and the financial sustainability of hospitals serving low-income patients.